Form 4: Schrodinger Executive Kenneth Patrick Lorton Reports Stock Option Grant

Kenneth Patrick Lorton, EVP, CTO & COO, Software at Schrodinger, Inc., reported the acquisition of stock options on March 21, 2024.

Summary

• Kenneth Patrick Lorton, an executive at Schrodinger, Inc., filed a Form 4 with the SEC.
• The filing reports the grant of stock options to Lorton on March 21, 2024.
• Lorton acquired options to purchase 30,000 shares of Schrodinger's common stock at an exercise price of $27.51 per share.
• The options vest over a period of four years, starting with 25% vesting on March 4, 2025, and the remainder vesting in equal monthly installments through March 4, 2028.
• Following the transaction, Lorton directly owns options for 30,000 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The grant of stock options is a standard practice and suggests confidence in the executive's ability to contribute to the company's success. However, it's not a major event that would drastically alter investor sentiment.

Positives

• The grant of stock options to a key executive like Kenneth Patrick Lorton aligns his interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the options.

Industry Context

Stock option grants are a common form of executive compensation in the technology and biotechnology industries, used to incentivize performance and retain key personnel. Schrodinger operates in a competitive market for talent, and these grants are likely part of a broader compensation strategy.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for executives in the tech and biotech industries.
• Companies like Moderna, BioNTech, and Recursion Pharmaceuticals also utilize stock options to incentivize their leadership teams.
• The vesting schedule of Schrodinger's options is fairly typical, with a four-year vesting period and a one-year cliff.
• The specific number of options granted and the exercise price would need to be compared against industry benchmarks for similar roles and company size to determine if it is above or below average.

Stakeholder Impact

• Shareholders may view the option grant as a positive sign, aligning executive interests with company performance.
• Employees may see this as a positive sign of investment in leadership.
• The grant has no immediate impact on customers, suppliers, or creditors.

Key Dates